Search
Search Results
-
Embryonic Stem Cells and the Law Crafting A Humane System of Regulation
This book deals with the research and use of embryonic stem cells to combat a number of diseases and the legal limitations, arising mostly from...
-
Predictions
Coming up with a prediction in situations such as the one at hand are often very difficult. As this book is centered around a groundbreaking, yet...
-
Delimitation of the Problem
In this chapter, which is seeks to offer a delimitation of the problem at hand, there is an in-depth primer on stem cells which includes what they...
-
Claims, Conflicting Claimants, and Their Reasoning
This chapter seeks to identify and explain the reasons behind each of the different arguments either for or against the expansion of embryonic stem...
-
Introduction
This chapter offers an introduction as to what the New Haven method of policy-oriented jurisprudence is and provides, including why it is seen as a...
-
Recommendations
After analyzing such a controversial topic in such an exhaustive matter, one can start to formulate their own recommendations based on everything...
-
Appraisal
An appraisal is required by the New Haven approach which looks to eight identified “values” that have been determined that all human begins cherish,...
-
Past Trends in Decisions and Conditioning Factors
This chapter offers a comprehensive look at every applicable law and legal decision as it relates to embryonic stem cells. This part contains...
-
Regulation of Genome Editing in Human iPS Cells A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies
The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and...
-
Regulation of Genome Editing in Human iPS Cells: France
The French legal framework on genome editing of human iPS cells is complicated as it relies on multiple applicable laws (European Union law, Council...
-
Regulation of Genome Editing in Human iPS Cells: Switzerland
In Switzerland, gene/cell therapies using genome edited iPSCs for somatic differentiation are generally permitted. Although Swiss Law does not...
-
Introductory Remarks
This introductory chapter will deliver insight into the background of this volume which forms an important outcome of an interdisciplinary research...
-
Regulation of Genome Editing in Human iPS Cells: Japan
Regenerative medicine based on genome-edited induced pluripotent stem cells (iPS cells) is regulated under the Pharmaceutical and Medical Device Act...
-
Regulation of Genome Editing in Human iPS Cells: United States
The United States (U.S.) has ever been, and still is, a world leader in the field of cell and gene therapies. This is mirrored by the US regulatory...
-
Regulation of Genome Editing in Human iPS Cells: Republic of Korea
Regarding the regulation of genome editing of human iPS cells in Korea, the Bioethics Act (2004) and the Advanced Regenerative Medicine Act (2019)...
-
Introduction to Genome Editing in Induced Pluripotent Stem Cells, Gametes, and Embryos
This chapter discusses recent findings and technological advances in stem cell biology, in gametogenesis, in genetic engineering and in the potential...
-
Regulation of Genome Editing in Human iPS Cells: Germany
Until 2021, ten GTMPs and one CTMP have been authorised in the EU and fifteen further are expected to become available by 2023—an augmentation that...
-
Comparative Analysis
The country reports (Chaps. 3–8) form the essential basis of this final chapter. It provides a comparative analysis the purpose of which is to...
-
Balancing of Individual Rights and Research Interests in Danish Biobank Regulation
Denmark offers very good opportunities for biobank research. There is a vast number of well-structured and comprehensive collections of biological...
-
Biobanks and GDPR: A Look at the Portuguese Panorama
The need for the existence of biobanks for health research purposes is something of which government authorities have been aware for several years....